You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

anti-nerve growth factor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Brain-derived Neurotrophic Factor Single Nucleotide Gene

Recruiting
  • Allergic Rhinitis
  • Genotyping.
  • Sohag, Egypt
    Sohag university Hospital
Jun 15, 2023

Nerve Growth Factor Expression in Pediatric Severe Burns:Pilot

Completed
  • Burns
  • pediatric patients affected by severe burns
  • Rome, Italy
    Giorgio Conti
Mar 1, 2023

Acute Kidney Injury in Cancer Patients Receiving Anti-Vascular

Completed
  • AKI Incidence of Cancer Patients Receiving AntiVEGF or ICIs
  • Wenzhou, Zhejiang, China
    The First Affiliated Hospital of Wenzhou Medical University
Nov 6, 2023

Optic Pathway Glioma Trial in Rome (CHF6467, Placebo)

Not yet recruiting
  • Optic Pathway Glioma
  • Rome, Italy
    Catholic University, Policlinico A. Gemelli (Hospital)
Feb 17, 2023

Injury of Optic Nerve Trial in Beijing (Recombinant human nerve growth factor injection,experimental, Recombinant human nerve

Recruiting
  • Injury of Optic Nerve
  • Recombinant human nerve growth factor injection,experimental
  • +2 more
  • Beijing, Beijing, China
    Beijing Tongren Hospital
Aug 10, 2021

Adult Diabetic Macular Edema and Suboptimal Response to

Not yet recruiting
  • Diabetic Macular Edema
    • (no location specified)
    Jul 31, 2023

    Macular Edema Due to Type 2 Diabetes Trial in Hangzhou (Anti-VEGF, subthreshold micropulse laser)

    Recruiting
    • Macular Edema Due to Type 2 Diabetes Mellitus
    • Hangzhou, Zhejiang, China
      Second Affiliated Hospital, School of Medicine, Zhejiang Univers
    Feb 26, 2023

    Dry Eye Syndrome Trial in Wien (rhNGF 20 µg/mL, rhNGF 4 µg/mL)

    Completed
    Has Results
    • Dry Eye Syndrome
    • rhNGF 20 µg/mL
    • rhNGF 4 µg/mL
    • Wien, Austria
      Department of Clinical Pharmacology
    Dec 14, 2022

    OPTImal PALliative Anti-epidermal Growth Factor Receptor

    Active, not recruiting
    • Colorectal Cancer Metastatic
    • +5 more
    • Plasma circulating DNA analysis
    • Aarhus, Denmark
      Aarhus University Hospital
    Feb 24, 2022

    Ischemic Stroke Trial in Hangzhou (nerve growth factor, physiological saline, EA)

    Recruiting
    • Ischemic Stroke
    • nerve growth factor
    • +3 more
    • Hangzhou, Zhejiang, China
      The Third Affiliated Hospital of Zhejiang Chinese Medical Univer
    Dec 14, 2022

    Breast Cancer Trial in Sarasota, Nashville (AC699)

    Recruiting
    • Breast Cancer
    • Sarasota, Florida
    • +1 more
    Jan 3, 2023

    Diabetic Macular Edema, Cataract Trial in Walnut Creek (Bevacizumab, Ranibizumab, Aflibercept)

    Recruiting
    • Diabetic Macular Edema
    • Cataract
    • Walnut Creek, California
      Bay Area Retina Associates
    Mar 1, 2022

    Following Intensive Anti-VEGF Therapy in Wet AMD

    Completed
    • Age-Related Macular Degeneration
    • Budapest, Hungary
    • +1 more
    Dec 28, 2022

    Retinal Vein Occlusion Trial in Winston-Salem (Aflibercept Ophthalmic)

    Recruiting
    • Retinal Vein Occlusion
    • Aflibercept Ophthalmic
    • Winston-Salem, North Carolina
      Wake Forest Health Sciences
    Jan 5, 2022

    Acute Ischemic Stroke Trial in Nanjing (Nerve Growth Factors, normal saline)

    Completed
    • Acute Ischemic Stroke
    • Nerve Growth Factors
    • normal saline
    • Nanjing, Jiangsu, China
      Department of Neurology, Jinling Hospital
    Aug 29, 2021

    Corneal Disease, Neuropathy Trial in Boston (Cenegermin-Bkbj)

    Withdrawn
    • Corneal Disease
    • Neuropathy
    • Boston, Massachusetts
      Tufts Medical Center
    Jan 18, 2023

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, biological, drug,

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +3 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +8 more
    • Duarte, California
      City of Hope Medical Center
    Jan 12, 2023

    Anti-VEGF in Real-world

    Recruiting
    • Neovascular Age-related Macular Edema
    • +5 more
    • Beijing, Beijing, China
      Wen-Bin Wei
    Feb 2, 2022

    Nerve Growth Factor for the Treatment of Cornea Disease

    Completed
    • Neurotrophic Keratitis
    • Stanford, California
      Stanford University
    Dec 10, 2021

    Exudative Age Related Macular Degeneration Trial in Winston-Salem (Ranibizumab, Photodynamic laser treatment (PDT),

    Not yet recruiting
    • Exudative Age Related Macular Degeneration
    • Winston-Salem, North Carolina
      Wake Forest Health Sciences
    Nov 28, 2022

    Metastatic Lung Non-Small Cell Carcinoma, Refractory Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer American Joint

    Recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • +4 more
    • Necitumumab
    • +4 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Jan 5, 2023

    HIV, Peripheral Nervous System Disease Trial in United States (Nerve Growth Factor, Recombinant Human)

    Completed
    • HIV Infections
    • Peripheral Nervous System Disease
    • Nerve Growth Factor, Recombinant Human
    • Los Angeles, California
    • +13 more
    Oct 27, 2021

    Metastatic Colorectal Cancer, Non Small Cell Lung Cancer Metastatic, Non Small Cell Lung Cancer Recurrent Trial in Hefei

    Completed
    • Metastatic Colorectal Cancer
    • +2 more
    • Hefei, Anhui, China
      The Second Hospital of Anhui Medical University
    Oct 27, 2021

    Intravitreal Injection Site and Perceived Pain

    Recruiting
    • Pain
    • Intravitreal injection site
    • Galveston, Texas
      University of Texas Medical Branch
    Jan 19, 2023

    Ocular Adverse Events in Neovascular Age-related Macular

    Completed
    • Age-related Macular Degeneration (AMD)
    • Aflibercept
    • +2 more
    • East Hanover, New Jersey
      Novartis Investigative Site
    Dec 15, 2021